These findings positioned the PI3K/Akt/mTOR pathway as an essential regulator of SREBP1-mediated MUFA lipogenesis, with combinatorial DDR1 inhibition and CIR disrupting this pro-survival metabolic circuit to drive ferroptotic elimination of tumor cells. The gene discussed is SREBF1; the disease is neoplasm.